Share this post on:

Name :
KDM4D antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
KDM4D Rabbit Polyclonal antibody. Positive WB detected in PC-3 cells. Observed molecular weight by Western-blot: 58-63 kDa

Tested applications :
ELISA, WB

Species reactivity :
Human; other species not tested.

Alternative names :
FLJ10251 antibody; JHDM3D antibody; JMJD2D antibody; KDM4D antibody; lysine (K) demethylase 4D antibody; Lysine specific demethylase 4D antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of KDM4D recombinant protein (Accession Number: NM_018039). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:200-1:2000

Background :
KDM4D represents lysine (K)-specific demethylase 4D

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Caspase-10 Antibody
GFAP Antibody (YA755)
Calpastatin Antibody: Calpastatin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 120 kDa, targeting to Calpastatin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Share this post on:

Author: Gardos- Channel